DAPTA
DAPTA (Adaptavir) is a small molecule CCR5 antagonist with demonstrated anti-HIV activity. It is a research tool for studying viral entry mechanisms and has been utilized in both in vitro assays and in vivo animal models of HIV infection.
Product Specifications
Product Name Alternative
HIV Protease, HIV, HIVProtease, CCR, CCR5, Adaptavir, CC chemokine receptor, D-Ala-peptide T-amide, DAPTA
Field of Research
Immunology & Inflammation, Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
>99.99% (May vary between batches)
Solubility
DMSO:10 mM
Molecular Weight
856.88
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP63366_P050-FITC 100 µL
COQ9 Antibody - N-terminal region : FITC (ARP63366_P050-FITC)
Sign In for Pricing
View Details 
